Wijngaard Peter
- SEC CIK
- 0001778501
No open-market purchases or sales filed in the past year.
Current role at each company
- HEPA Hepion Pharmaceuticals, Inc.Directoras of Nov 28, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Wijngaard Peter as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 28, 2023 (view filing) | Nov 24-27 | 4 days | Wijngaard PeterDirector | PPurchase | +5.00K | $3.07 | +$15.3K | +111.1%9.50K after | 2 lots |
| Sep 20, 2023 (view filing) | Sep 15-19 | 5 daysLate | Wijngaard PeterDirector | PPurchase | +3.00K | $5.61 | +$16.8K | +199.9%4.50K after | 4 lots |